7 min read

THE $5.1 BILLION US–NIGERIA HEALTH DEAL: WHAT DID TINUBU SIGN THAT GHANA REFUSED ?

SPECIAL FRONT-PAGE INVESTIGATION | 14 OCTOBER 2026

NAFDAC'S POWERS, NIGERIANS' MEDICAL RECORDS AND NATIONAL SOVEREIGNTY NOW UNDER SCRUTINY

When foreign medical assistance comes with conditions touching on the health information, biological samples and regulatory independence of a sovereign nation, the people have a right to know exactly what their government has agreed to.

By Dr. (The Rt. Hon.) Okey Umeano

A government that cannot adequately equip its hospitals, provide essential medicines, protect its healthcare workers or guarantee affordable treatment to millions of citizens must be especially careful when negotiating foreign medical assistance.

Nigeria has signed a multibillion-dollar health cooperation agreement with the United States of America. Ghana examined a similar proposal and refused to accept it on the terms presented.

The question confronting Nigerians today is simple: What did Ghana discover that made it reject the proposed agreement, and what safeguards did Nigeria secure before signing its own?

On December 19, 2025, the administration of President Bola Ahmed Tinubu entered into a five-year health cooperation Memorandum of Understanding with the United States.

Under the arrangement, Washington intends to provide approximately $2.1 billion in grants, while Nigeria is expected to mobilise nearly $3 billion in domestic health financing between April 2026 and December 2030.

These are the figures published by both governments. They contradict circulating claims that America is providing $3 billion while Nigeria contributes only $2.1 billion.

THE FINANCIAL COMMITMENTS

United States grants

$2.1bn

Nigeria's projected contribution

$3bn

Approximate five-year commitments, not evidence that the entire amount has already been disbursed.

This is not simply a shipment of free vaccines and drugs. It is a far-reaching arrangement involving disease surveillance, laboratory systems, medical commodities, health financing and information systems.

And that is precisely why the agreement deserves intense public scrutiny.

GHANA SAID NO. WHY DID NIGERIA SAY YES?

Ghana's rejection of a proposed American health agreement has brought a disturbing dimension to the controversy.

Ghanaian authorities raised concerns over access to sensitive medical records, pathogen information and the regulatory independence of their institutions.

President John Dramani Mahama subsequently disclosed concerns about provisions affecting the Ghana Food and Drugs Authority's ability to inspect imported medical products.

Reuters and the Associated Press independently reported Ghana's rejection and its concerns over health data sovereignty.

That decision deserves serious examination.

Ghana did not declare that all American medicines were dangerous. Rather, its government objected to conditions it considered unacceptable.

That distinction is important.

A nation can welcome medical assistance without surrendering its right to regulate the medicines administered to its citizens.

Nigeria must therefore explain whether similar provisions were presented during its negotiations and, if so, whether they were accepted, rejected or modified.

NAFDAC MUST NEVER BECOME A SPECTATOR

The National Agency for Food and Drug Administration and Control exists to protect Nigerians against unsafe, substandard, falsified and improperly regulated medical products.

Its responsibilities must not be compromised by political agreements, diplomatic pressure or financial inducements.

An allegation circulating publicly claims that Nigeria agreed to prevent NAFDAC from testing vaccines and medicines supplied under the American arrangement.

That allegation has not been established by the available evidence.

Nevertheless, the government must answer it unequivocally.

Does NAFDAC retain full legal authority to inspect, assess, register, monitor and, where scientifically necessary, independently test medical products supplied under this programme?

Does the agreement contain any provision limiting that authority?

Will NAFDAC have access to the relevant manufacturing, quality-control and safety documentation?

No foreign donor, regardless of its economic or military strength, should dictate that Nigerian regulators abandon their statutory responsibilities.

At the same time, Nigerians must understand that not every vaccine batch requires duplicate laboratory testing before use. Regulatory independence includes the authority to apply internationally accepted scientific procedures.

The essential principle is that the final regulatory responsibility for medicines used in Nigeria must remain with competent Nigerian authorities.

OUR MEDICAL RECORDS ARE NOT DIPLOMATIC GIFTS

Perhaps the most consequential issue concerns the ownership, access, storage and international transfer of Nigerian health information.

Modern medical data can contain extraordinarily sensitive details about individuals and populations.

Such information may include disease prevalence, laboratory results, genetic information, geographical disease patterns and other confidential records.

Medical cooperation may legitimately require the sharing of carefully controlled public-health information.

But who determines what may be shared?

Who controls access?

Where will the information be stored?

Can identifiable patient records be transferred abroad?

What happens when the agreement expires?

And what safeguards prevent information collected for disease prevention from being used for unrelated purposes?

These questions are not anti-American. They are fundamental questions of medical ethics, patient confidentiality and national sovereignty.

Indeed, a legal challenge filed at the Federal High Court in Abuja has already questioned aspects of the agreement, including privacy, transparency and constitutional oversight.

WHY IS A COUNTRY STRUGGLING TO FINANCE HEALTHCARE PROMISING BILLIONS?

Nigeria's financial commitment deserves equally rigorous examination.

The federal government has repeatedly complained of inadequate revenue, while public hospitals struggle with equipment shortages, poor infrastructure and insufficient resources.

Yet Nigeria is projected to mobilise nearly $3 billion under this five-year arrangement.

Where will this money come from?

How much will be provided by the Federal Government, and how much by the states?

Will these allocations represent genuinely additional healthcare spending, or merely the relabelling of existing budgetary commitments?

Who will audit the expenditure?

Which institutions will receive the money?

And how will Nigerians measure the results?

The Ministry of Health says the agreement requires Nigeria to devote at least six percent of executed federal and state budgets to health, with the aim of strengthening long-term self-reliance.

That objective may be defensible.

But promises are not performance.

Nigeria needs functioning hospitals, essential medicines, effective disease prevention, trained professionals and measurable improvements in survival rates.

Not another international agreement whose financial obligations are celebrated while its implementation remains obscure.

THE SOUTHEAST MUST NOT BECOME A POLITICAL EXPERIMENT

Public commentary has suggested that a disproportionate quantity of medicines and vaccines could be directed to Southeastern Nigeria, possibly for political purposes.

No credible evidence presently establishes that such a plan exists.

Nevertheless, the distribution of medical assistance must be transparent across all six geopolitical zones.

Healthcare must never become a weapon of electoral manipulation.

The people of the Southeast, like Nigerians in the Northeast, Northwest, North Central, Southwest and South-South, deserve equitable access to safe, effective medical services.

Allocation should be determined by population needs, disease burden, epidemiological evidence and established public-health priorities.

Not party loyalty.

Not political patronage.

Not the electoral ambitions of governors, ministers or legislators.

And certainly not ethnicity or religion.

LET US NOT TURN LEGITIMATE FEAR INTO A PUBLIC-HEALTH DISASTER

There is another danger that must be addressed.

Some public statements have gone beyond questioning the agreement to suggest that American vaccines and medicines are intended to cause deaths or reduce Nigeria's population.

Such allegations require compelling scientific evidence.

None has been established in the material examined.

As a medical practitioner, I consider it essential to distinguish regulatory vigilance from unsupported accusations of deliberate poisoning.

Vaccines and properly regulated medicines have saved countless lives. Malaria, tuberculosis, HIV and other infectious diseases remain serious threats to Nigerians.

It would be tragic if legitimate questions about an international agreement persuaded parents to deny their children essential immunisations or patients to abandon effective treatment.

We must protect Nigerians both from unsafe medical products and from misinformation that discourages lifesaving healthcare.

Those objectives are not contradictory.

They are complementary responsibilities of a serious government.

THE NATIONAL ASSEMBLY MUST WAKE UP

The National Assembly cannot remain silent when an international agreement raises questions about public expenditure, data protection and regulatory sovereignty.

The Senate and House of Representatives should urgently conduct public hearings.

The Minister of Health and Social Welfare, Professor Muhammad Ali Pate, should explain the negotiations, financial commitments and safeguards.

NAFDAC should state publicly whether its statutory authority remains fully intact.

The Nigeria Data Protection Commission should examine the provisions governing personal medical information.

And the Federal Government should disclose the complete agreement, including any annexes, implementation protocols and subsequent amendments.

The document should be accessible to medical professionals, lawyers, civil society organisations, researchers and ordinary Nigerians.

International diplomacy cannot become an excuse for withholding information that directly affects the health and rights of citizens.

MR PRESIDENT, NIGERIANS DESERVE ANSWERS

President Bola Ahmed Tinubu must recognise that this controversy cannot be resolved by government assurances alone.

It requires documentary transparency.

The Presidency should answer these questions:

  • What exactly did Nigeria agree to on December 19, 2025?
  • Were provisions restricting independent inspection of imported medical products proposed during negotiations?
  • Does NAFDAC retain unrestricted statutory regulatory authority?
  • What medical data or biological specimens may be transferred abroad?
  • Who controls the storage, access and eventual disposal of those materials?
  • What is the precise financial obligation of the Federal Government and each participating state?
  • What safeguards ensure fair distribution of medicines across Nigeria?
  • What mechanisms allow Nigeria to suspend or terminate the agreement if its national interests are threatened?

These questions deserve official, documented answers.

THE HEALTH OF 200 MILLION PEOPLE IS NOT NEGOTIABLE

Nigeria is not a medical laboratory belonging to any foreign power.

Neither is Nigeria a helpless nation that must surrender its institutions before receiving international assistance.

We should welcome genuine cooperation that strengthens hospitals, saves children, prevents infectious diseases and improves the lives of our people.

But such cooperation must operate within Nigerian law and under transparent, independent scientific supervision.

Ghana's decision demonstrates that African governments can scrutinise proposed international agreements and reject conditions they consider unacceptable.

Nigeria must demonstrate that it exercised comparable judgment.

If the agreement contains adequate protections, publish them and reassure the nation.

If it contains unacceptable restrictions, renegotiate them.

If public officials have exceeded their lawful authority, hold them accountable.

And if the agreement is beneficial, demonstrate that benefit through measurable improvements in Nigerian healthcare.

The demand is not that Nigeria should reject American medical assistance. The demand is that Nigeria must never exchange its regulatory independence, its citizens' privacy or its sovereign rights for financial assistance.

For too long, Nigerians have been expected to trust political leaders without being allowed to examine the documents signed in their name.

That era must end.

MR PRESIDENT, PUBLISH THE AGREEMENT. LET NAFDAC SPEAK. LET THE NATIONAL ASSEMBLY INVESTIGATE. LET NIGERIANS KNOW THE TRUTH.

Because no amount of foreign aid is worth the surrender of a nation's responsibility to protect its people.

Editorial documentation: Federal Ministry of Health and Social Welfare, 19 December 2025; US Department of State announcement; Reuters and Associated Press reporting on Ghana; Premium Times reporting on the Nigerian legal challenge; and October 2026 reporting on renewed calls for disclosure.

Type at least two letters to search titles, summaries and topics.